loading page

Erythema multiforme-like bullous pemphigoid following COVID-19 mRNA vaccine
  • +2
  • Azza Ghannem,
  • Faten Rabhi,
  • Faten Gargouri,
  • Kahena Jaber,
  • Raouf Dhaoui
Azza Ghannem
Military Hospital of Instruction of Tunis

Corresponding Author:[email protected]

Author Profile
Faten Rabhi
Military Hospital of Instruction of Tunis
Author Profile
Faten Gargouri
Military Hospital of Instruction of Tunis
Author Profile
Kahena Jaber
Military Hospital of Tunis
Author Profile
Raouf Dhaoui
Military Hospital of Instruction of Tunis,
Author Profile

Abstract

Cases of bullous pemphigoid following Covid-19 vaccines have been recently reported. We describe herein an atypical case of acral bullous pemphigoid after Pfizer BionTech vaccine. Clinicians should be aware of this reaction and encourage full vaccination as the disease displays a rapid improvement treatment.
02 Oct 2022Submitted to Clinical Case Reports
11 Oct 2022Submission Checks Completed
11 Oct 2022Assigned to Editor
16 Oct 2022Reviewer(s) Assigned
11 Dec 2022Review(s) Completed, Editorial Evaluation Pending
15 Mar 2023Editorial Decision: Revise Minor